We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.3%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$12.8B
AUM Growth
+$1.1B
(+9.4%)
Cap. Flow
+$840M
Cap. Flow
% of AUM
6.56%
Top 10 Holdings %
Top 10 Hldgs %
12.13%
Holding
2,105
New
79
Increased
1,204
Reduced
715
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$16.2M |
| 2 |
Johnson & Johnson
JNJ
|
+$15.2M |
| 3 |
AT&T
T
|
+$14.3M |
| 4 |
ExxonMobil
XOM
|
+$14.1M |
| 5 |
IBM
IBM
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$21.6M |
| 2 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$12.3M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$11.1M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$7.05M |
| 5 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$6.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.06% |
| 2 | Healthcare | 14.21% |
| 3 | Technology | 14.12% |
| 4 | Consumer Staples | 9.51% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
101
DELISTED
Walgreens Boots Alliance
WBA
| $29.3M | 0.23% |
351,772
+10,154
| +3% | +$819K |
|
102
Colgate-Palmolive
CL
$74.8B
| $28.8M | 0.23% |
393,546
+12,558
| +3% | +$894K |
|
103
British American Tobacco
BTI
$136B
| $28.8M | 0.22% |
444,626
-4,264
| -0.9% | -$258K |
|
104
Elevance Health
ELV
$81.5B
| $28.7M | 0.22% |
218,240
+11,600
| +6% | +$1.59M |
|
|
AET
105
DELISTED
Aetna Inc
AET
| $28.4M | 0.22% |
232,761
+25,395
| +12% | +$2.92M |
|
106
Simon Property Group
SPG
$76.4B
| $28.3M | 0.22% |
130,254
+2,267
| +2% | +$463K |
|
107
Duke Energy
DUK
$101B
| $27.8M | 0.22% |
324,262
+38,873
| +14% | +$3.11M |
|
108
RenaissanceRe
RNR
$13.8B
| $27.6M | 0.22% |
235,130
+7,467
| +3% | +$857K |
|
|
CA
109
DELISTED
CA, Inc.
CA
| $27.5M | 0.22% |
838,849
+88,087
| +12% | +$2.76M |
|
110
Booking.com
BKNG
$156B
| $27.5M | 0.21% |
550,325
-7,100
| -1% | -$369K |
|
111
National Grid
NGG
$79.3B
| $27M | 0.21% |
377,049
+19,896
| +6% | +$1.38M |
|
|
EMC
112
DELISTED
EMC CORPORATION
EMC
| $26.9M | 0.21% |
988,872
+131,475
| +15% | +$3.55M |
|
113
Korea Electric Power
KEP
$14.6B
| $26.7M | 0.21% |
1,029,951
-37,685
| -4% | -$972K |
|
|
TWX
114
DELISTED
Time Warner Inc
TWX
| $26.2M | 0.2% |
356,365
+14,441
| +4% | +$1.07M |
|
|
ESRX
115
DELISTED
Express Scripts Holding Company
ESRX
| $25.5M | 0.2% |
336,832
+29,292
| +10% | +$2.15M |
|
116
American Express
AXP
$224B
| $25.3M | 0.2% |
416,561
+61,575
| +17% | +$3.9M |
|
117
Target
TGT
$66.3B
| $24.9M | 0.19% |
357,274
+5,322
| +2% | +$397K |
|
|
RTN
118
DELISTED
Raytheon Company
RTN
| $24.7M | 0.19% |
181,876
+25,599
| +16% | +$3.33M |
|
119
General Motors
GM
$80.9B
| $24.7M | 0.19% |
871,195
+52,877
| +6% | +$1.61M |
|
120
American Water Works
AWK
$27B
| $24.6M | 0.19% |
291,366
+177,535
| +156% | +$13.2M |
|
121
Northrop Grumman
NOC
$76B
| $24.3M | 0.19% |
109,326
+3,009
| +3% | +$633K |
|
|
AGN
122
DELISTED
Allergan plc
AGN
| $24.3M | 0.19% |
105,102
-6,578
| -6% | -$1.52M |
|
123
Goldman Sachs
GS
$289B
| $24M | 0.19% |
161,575
+11,862
| +8% | +$1.85M |
|
124
GSK
GSK
$107B
| $23.8M | 0.19% |
440,168
-18,892
| -4% | -$995K |
|
125
Southern Company
SO
$108B
| $23.5M | 0.18% |
437,471
-14,816
| -3% | -$745K |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q2 2016 Portfolio in Review
As of Q2 2016, Aperio Group held 2,105 positions worth $12.8B, up 9.4% from $11.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Aperio Group deployed $840M of net new capital in Q2 2016, opening 79 new positions and adding to 1,204 existing holdings. Its largest new stake was S&P Global: 119,543 shares worth $12.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Zimmer Biomet, an estimated $6.43M trimmed.
- Aperio Group's largest Q2 2016 buy was S&P Global: 119,543 shares worth $12.8M.
- Aperio Group added most to Novartis in Q2 2016, an estimated $16.2M increase.
- Aperio Group's biggest Q2 2016 reduction was Zimmer Biomet, cutting an estimated $6.43M.
- Aperio Group fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $21.6M.
- Aperio Group's ten largest holdings make up 12% of its $12.8B portfolio in Q2 2016.
- Aperio Group opened 79 new positions and closed 98 in Q2 2016.
- Aperio Group's portfolio value rose 9.4% quarter-over-quarter to $12.8B.
Based on Aperio Group's 13F filing for Q2 2016, filed 12 Aug 2016.